Bill Texts: NJ A2830 | 2020-2021 | Regular Session
Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.
Spectrum: Partisan Bill (Democrat 3-0)
Status: (Introduced - Dead) 2020-02-20 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A2830 Detail]
Spectrum: Partisan Bill (Democrat 3-0)
Status: (Introduced - Dead) 2020-02-20 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A2830 Detail]
Bill Drafts
Revision | Date | Format | Source | View |
---|---|---|---|---|
Introduced | 2020-02-20 | HTML/Text | Link | View |
Amendments
Amendment | Date | Disposition | Format | Source | View |
---|---|---|---|---|---|
No bill amendments currently on file for New Jersey A2830 |
Supplemental Documents
Title | Description | Date | Format | Source | View |
---|---|---|---|---|---|
No supplemental documents for New Jersey A2830 currently on file. |